Though our study was unable to demonstrate any prognostic significance for mRNA expression of LAT1 or ASCT2, the increased endothelial expression of these transporters supports further investigation into their potential as theranostic targets for glioma. The gene discussed is SLC1A5; the disease is central nervous system cancer.